Concepedia

Publication | Open Access

Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer

DOIFull Paper Access

56

Citations

29

References

2015

Year

Amit Mehta, Lisa Zhang, Myriem Boufraqech, Yi Liu‐Chittenden, Yaqin Zhang, Dhaval Patel, Sean Davis, Avi Z. Rosenberg, Kris Ylaya, Rachel Aufforth,
Clinical Cancer Research

Abstract

Our data show that YM155 is a promising anticancer agent for ATC and that its target, survivin, is overexpressed in ATC. Our findings support the use of YM155 in clinical trials as a therapeutic option in advanced and metastatic ATC.

References

YearCitations

Page 1